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Three Year Results of the DESSOLVE I ﬁrst-in-human trial and the
DESSOLVE II randomized trial of a sirolimus-eluting stent with fully absorbable
polymer
John Ormiston1, Charlene Knape2
1Mercy Angiography Unit, Auckland, New Zealand, 2Micell Technologies, Durham,
NC, USA
Objectives: Long-term clinical follow-up of new drug-eluting stents is essential to
ensure continued safety in patients treated with these DES in clinical practice. Two
clinical trials of the MiStent SES are currently in long-term follow-up; the DES-
SOLVE I clinical trial, a ﬁrst-in-human study of 30 patients conducted at 5 sites
evaluating the MiStent SES, and the DESSOLVE II clinical trial, a 2:1 randomized
study of 184 patients conducted at 26 sites evaluating the MiStent SES as compared to
the control stent, the Endeavor Sprint.
Methods: The MiStent SES uses a unique combination of a crystalline formu-
lation of sirolimus and a rapid, fully absorbable polymer on a thin-strut, cobalt
chromium stent platform. The polymer coating is eliminated from the stent in
45-60 days with complete tissue absorption within 90 days; however, uniquely,
the crystalline sirolimus continues to maintain therapeutic tissue levels of siro-
limus up to 9 months. In the trials, patients with discrete de novo lesions up to
27 mm in length in native coronary arteries were enrolled. The primary endpoint
of in-stent late lumen loss (LLL) was evaluated in both trials. Patients were also
followed for clinical events at predeﬁned intervals. MACE was deﬁned as all
death, Q and non-Q wave myocardial infarction and all target vessel
revascularization.
Results: The DESSOLVE I trial demonstrated minimal progression of late lumen loss
between 8 and 18 months follow-up (0.090.10 and 0.090.15) respectively, with no
target lesion MACE events through 3 years. In the DESSOLVE II trial, the MiStent
LLL was superior to the Endeavor LLL (0.270.46 versus 0.580.41). MACE for
MiStent SES and Endeavor was 4.3% versus 6.7% (P¼0.49) respectively at 9 months,
5.1% versus 8.3% (P¼0.51) at 12 months, and 6.7% versus 13.3% (P¼0.167) at
2 years. Evaluation of imaging (angiographic, IVUS, OCT) at various time points and
clinical outcomes of the MiStent SES for DESSOLVE I and DESSOLVE II to 3 years
will be presented.
Conclusions: The MiStent SES is a unique DES combining short-term polymer
exposure of 3 months with a long-term sirolimus elution proﬁle of 9 months. These
studies verify the efﬁcacy of the MiStent SES with a sustained safety proﬁle.
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Preventive effects of cordyceps sinensis against contrast induced nephropathy
in type 2 diabetics with renal insufﬁciency undergoing coronary angiography
Zhao Kai, Gao Sheng, Li Yongjian, Zhang Boya, Lin Yu, Jin Zhe, Zhao Kai
Department of Cardiology, Tianjin Nankai Hospital
Objectives: To study the preventive effects of cordyceps sinensis (CS) against
contrast induced nephropathy (CIN) in type 2 diabetics with renal insufﬁciency un-
dergoing coronary angiography.
Methods: A total of 210 patients with type 2 diabetes and estimated glomerular
ﬁltration rate (eGFR) of 60ml/min/1.73m2 or less, were randomly divided into three
groups, basic treatment group (n¼71), standard CS therapy group (n¼69, corbrin
capsule 2g, 3 times/d were used 3 days before and after angiography), and intensive
CS therapy group (n¼70, corbrin capsule 3g, 3 times/d were used 3 days before and
after angiography). Serum creatinine (Scr) and eGFR were assessed at the time of
hospital admission and on days 1, 2, and 3 after angiography. The values of urine
neutrophil-gelatinase-associate-lipocalin (NGAL), kidney injury molecule-1 (KIM-1),
and interleukin-18 (IL-18) were detected before angiography and 1 day after angi-
ography in the patients of three groups. The primary end point was the prevalence of
CIN. The secondary end point was a 25% or greater reduction in eGFR.
Results: CIN occurred in 19 of 210 patients (9.04%). The prevalence of CIN was
lower in the CS treatment groups than in the basic treatment group (P<0.05), and
a signiﬁcant decrease in the prevalence of CIN in the intensive CS therapy group
was shown (P<0.01). Compared with the basic treatment group, a lower pro-
portion of patients in the CS treatment groups had an eGFR decrease of 25% or
greater (P<0.05) ; patients with an eGFR decrease of 25% or greater accounted
for even lower proportion in the intensive CS therapy group and a statistical
signiﬁcance was reached (P<0.01). Within 1 day after the procedure, urine
levels of KIM-1, NGAL, and IL-18 in patients in the intensive CS therapy
group were lower than those in the basic treatment group and standard therapy
group (P<0.05). Multiple Logistic Regression showed that advanced age, lower
eGFR levels, and higher dose of contrast volume were independent risk factors
of CIN.
Conclusions: CS is a protective factor against CIN in type 2 diabetics with renal
insufﬁciency undergoing coronary angiography and intensive CS therapy could be
more effective.C138 JACC Vol 64/16/Suppl C j October 16–1GW25-e0278
Coronary Flow Reserve in the Remote Myocardium Predict Left Ventricular
Remodeling Following Acute Myocardial Infarction
Cheng Rongchao1, Wei Guoqian1, Yu Longhao1, Wei Li1, Tian Jiawei2, Li Xueqi1
1the Forth Afﬁliated Hospital of Harbin Medical University, 2the second Afﬁliated
Hospital of Harbin Medical University
Objectives: The objective of the present study was to assess whether a relationship
exists between CFR in the non-infarcted myocardium and left ventricular remodeling
following AMI.
Methods:We enrolled 42 consecutive patients undergoing PCI. All patients were
subjected to two-dimensional echocardiography (2-DE) and real-time myocardial
contrast echocardiography (RT-MCE) to assess left ventricular function and CFR
one week following PCI. RT-MCE was performed both at rest and during
dobutamine infusion to assess CFR in the infarcted myocardium and non-
infarcted myocardium. After six months, 2-DE was repeated to reassess left
ventricular function. The remodeling was deﬁned as an increase in LVEDV by at
least more than 20%. Twenty subjects were enrolled as the control group and
were examined using the same method to assess CFR. cTnI levels were routinely
analyzed on admission as a serum speciﬁc marker of myonecrosis and repeated
every six hours during the ﬁrst 24 hours post-PCI in order to estimate peak
concentration.
Results: Compared with the infarcted myocardium and non-infarcted myocar-
dium, both at baseline and following low dose dobutamine administration,
myocardial blood ﬂow (MBF) in the non-infarcted myocardium was signiﬁcantly
higher than in the infarcted myocardium, and mean CFR of the non-infarcted
myocardium was also signiﬁcantly higher than observed in the infarcted
myocardium (2.650.31 vs.2.130.25, P<0.01). There was no difference
observed in MBF between the non-infarcted myocardium and normal myocar-
dium at baseline, while at peak stress, MBF in the normal myocardium was
signiﬁcantly increased than that in the non-infarcted myocardium (11.21.11 vs.
8.982.53 dB/s, P<0.05). Mean CFR was also higher compared to the non-
infarcted myocardium (3.080.29 vs. 2.650.31, P<0.01). According to CFR
cut-off value of 2.39 in the non-infarcted myocardium as providing the maximal
accuracy to distinguish between patients with impaired CFR and preserved CFR,
all patients were divided into two subgroups: Group I (CFR<2.39) and Group II
(CFR2.39). The levels of cTnI were higher in Group I compared to Group II
on admission (36.40 vs.21.38mg/ml, P<0.05). Furthermore, at six months
following coronary angioplasty, LVEDV and LVESV in Group I were increased
(132 vs. 137 ml, and 69 vs. 76 ml, respectively), and lLVFF was decreased
(47% vs. 45%). In Group II, LVEDV and LVESV was decreased (131 vs. 128
ml, and 68 vs. 59 ml, respectively), while LVEF was increased (48% vs. 53%).
There are nine patients with remodeling in Group I while only two in Group II.
Furthermore, we analyzed the correlation between CFR in the non-infarcted
myocardium and parameters of LV function. There was a signiﬁcant negative
correlation between CFR and LVEDV, LVESV in the non-infarcted myocardium
(r¼-0.623, P<0.001, r¼-0.696, P<0.001, respectively). LVEF and CFR in the
non-infarcted myocardium were also correlated with each other (r¼0.658,
P<0.001).
Conclusions: Microvascular dysfunction is commonly observed in the non-infarcted
myocardium. The CFR value in the non-infarcted myocardium accurately predicts
adverse left ventricular remodeling following AMI.GW25-e1117
Rotational Atherectomy Combined with Cutting Balloon for the Treatment of
Severely Calciﬁed Coronary Lesions: An Intravascular Ultrasound Study
Tang Zhe, Bai Jing, Wang Yu
Chinese PLA General Hospital
Objectives: The intravascular ultrasound (IVUS) study was designed to evaluate the
immediate efﬁcacy and safety of rotational atherectomy combined with cutting
balloon for severely calciﬁed coronary lesions.
Methods: Eighty consecutive patients with severely calciﬁed coronary lesions which
were deﬁned by coronary angiography and IVUS (calcium arc180, calcium length
ratio0.5) and deposed by rotational atherectomy were divided into 2 groups. There
were 34 in rotational atherectomy (RA) group and 46 in rotational atherectomy
combined with cutting balloon (RC) group. In all lesions, we used RA to ﬁrst depose
the stenosis. In RC group, after RA, we used cutting balloon for the future plaque
modiﬁcation. The size of RA bur and cutting balloon are recorded.IVUS was per-
formed before percutaneous coronary intervention (PCI) to measured lumen cross-
sectional area (CSA), external elastic membrane (EEM), Plaque and media CSA ¼
EEM CSA-lumen CSA. Lumen CSA of every 1 mm of culprit lesion segment was
measured and average lumen CSA was calculated. For calcium, we measured
maximum calcium arc, calcium length, and calcium ratio (calcium length/lesion
length). After stent implantation, IVUS was rechecked to measure minimum stent
CSA, minimum and maximum stent diameter, and the reference lumen CSA. Stent
symmetry ¼ minimum stent diameter/maximum stent diameter. Stent expansion ¼
minimum stent CSA/reference lumen CSA. Incomplete stent apposition was deﬁned
as insufﬁciently close contact between some struts and the underlying wall. What’s9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
more, the occurrence of slow-ﬂow, no-reﬂow, vessel dissection and branch vessel jail
are recorded.
Results: Baseline demographics and clinical characteristics, including age, sex,
smoking, ect, were similar between the two groups. There were not signiﬁcantly
different in baseline lesion characteristics. The maximum calcium arc and
calcium length ratio were (215.921.8) and (0.720.06) in RA group matched
with (226.521.6) and (0.780.05) in RC group, P>0.05. Before stent im-
plantation, the minimum lumen CSA was (2.520.07) mm2 in RA group and
(2.460.09) mm2 in RC group, without difference.The size of RA bur was
(1.44+0.02) mm and (1.46+0.01) mm in two groups, P>0.05. The cutting
balloon diameter used in RC group was (2.56+0.04) mm. The stent size were
(2.93+0.08) mm in RA group and (3.09+0.08) mm in RC group, P>0.05. After
RA and RA combined cutting balloon, there were 12 (35.3%) cases in RA
group and 26 (56.5%) cases in RC group could see the gaps, P¼0.189.
Although there was no statistical deference between the two groups, there was a
trend in RC group that more cases appear gaps after the adequate plaque
modiﬁcation.After stent implantation, the minimum stent area after stent im-
plantation and acute lumen gain of RC group were signiﬁcantly greater than
that of the RA group ((6.120.37) mm2 vs (5.420.24) mm2, P¼0.012;
(3.660.34) mm2 vs (2.900.24) mm2, P¼0.016). There were no statistical
differences in the occurrence of slow ﬂow, no-reﬂow, branch vessel jail and
vessel dissection between the two groups.
Conclusions: Rotational atherectomy combined with cutting balloon for treatment of
severely calciﬁed coronary lesions could signiﬁcantly increase the stent area, acute
lumen gain compared with rotational atherectomy alone, without increasing the PCI-
related complications.GW25-e1118
The Inﬂuence of Calcium Parameters for Immediate PCI Results:
An Intravascular Ultrasound Analysis
Tang Zhe, Bai Jing, Wang Yu
Chinese PLA General Hospital
Objectives: This IVUS study was designed to evaluate how calciﬁed parameters
(including calcium arc, calcium length ratio and calcium index) inﬂuence the results of
PCI.
Methods: From January 2012 to October 2012, 105 consecutive coronary artery
disease patients who underwent primary angioplasty with IVUS were analyzed in
our center. There were 34 no-calciﬁed lesions (no calcium of all lesion seg-
ments), 32 light-calciﬁed lesions (calcium length ratio<0.5 or calcium arc<180),
and 40 severe-calciﬁed lesions (calcium length ratio0.5 and calcium
arc180).IVUS was performed before percutaneous coronary intervention (PCI)
to measured lumen cross-sectional area (CSA), external elastic membrane (EEM),
Plaque and media CSA ¼ EEM CSA-lumen CSA. Lumen CSA of every 1 mm
of culprit lesion segment was measured and average lumen CSA was calculated.
For calcium, we measured maximum calcium arc, calcium length, and calcium
ratio (calcium length/lesion length). After stent implantation, IVUS was
rechecked to measure minimum stent CSA, minimum and maximum stent
diameter, and the reference lumen CSA. Stent symmetry ¼ minimum stent
diameter/maximum stent diameter. Stent expansion ¼ minimum stent CSA/
reference lumen CSA. Stent malapposition was deﬁned as insufﬁciently close
contact between some struts and the underlying wall. Stent asymmetry was
deﬁned as stent symmetry of at least one section<0.7. Stent underexpansion was
deﬁned as stent expansion rate <0.8.
Results: Severely calciﬁed lesions had smaller minimum lumen CSA, mean lumen
area, and minimum stent lumen CSA after PCI. And in severely calciﬁed lesions,
there was a higher occurrence of vessel dissection, vessel jail, stent malapposition,
stent asymmetry, and stent under-expansion. In all calciﬁed lesions, calcium arc has
a stronger inﬂuence for minimum lumen area (R2¼0.174, P¼0.000), minimum
stent area (R2¼0.256, P¼0.000), acute lumen gain (R2¼0.168, P¼0.000), and stent
expansion (R2¼0.103, P¼0.003) than calcium length ratio (min lumen area:
R2¼0.005, P¼0.445; min stent area: R2¼0.085, P¼0.007; acute lumen gain:
R2¼0.074, P¼0.012; stent expansion: R2¼0.007, P¼0.222) and calcium index (min
lumen area: R2¼0.108, P¼0.002; min stent area: R2¼0.237, P¼0.000; acute lumen
gain: R2¼0.167, P¼0.000; stent expansion: R2¼0.086, P¼0.007). Calcium length
ratio has a stronger inﬂuence for vessel dissection (OR¼7.528, 95%CI 1.395-
40.643, P¼0.019) than calcium arc (OR¼1.005, 95%CI 1.001-1.010, P¼0.026) and
calcium index (OR¼5.647, 95%CI 1.195-26.678, P¼0.029). Calcium index
(R2¼0.261, P¼0.000) has stronger inﬂuence for mean lumen area and incomplete
stent apposition (OR¼19.658, 95%CI 3.233-119.509, P¼0.001) than calcium arc
(mean lumen area R2¼0.158, P¼0.000; incomplete stent apposition OR¼1.011,
95%CI 1.004-1.018, P¼0.001) and calcium length ratio (mean lumen area
R2¼0.236, P¼0.000; incomplete stent apposition OR¼12.945, 95%CI 1.766-
94.913, P¼0.012). Vessel loss seemed to have no liner relationship with calcium
parameters.
Conclusions: For calciﬁed lesions, we should consider both calcium arc and length.
The minimum lumen area, minimum stent area, acute lumen gain, and stent expansion
are mainly affected by calcium arc. Stent symmetry and the occurrence of vessel
dissection are mainly affected by calcium length ratio. Mean lumen area and stent
malapposition are mainly affected by calcium index.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CGW25-e2152
Ischemic Postconditioning versus Remote Ischemic Conditioning in Patients
Treated with Primary Percutaneous Coronary Intervention: A Bayesian
Network Meta-analysis
Wang Lei, Wang Jingping, Han Huiyuan, Xu Huiyu, Zhang Haozhou, Li Bao
Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, China
Objectives: The aim of present analysis was to compare ischemic postconditioning
(IPC) with remote ischemic conditioning (RIPC) in primary percutaneous coronary
intervention (pPCI), a network meta-analysis was performed using a Bayesian
approach.
Methods: Published randomized controlled trials included either IPC or RIPC in
patients with ST-elevation acute myocardial infarction (STEMI) during pPCI were
identiﬁed though the PubMed, EMBASE, and Cochrane central Register of Controlled
Trials database, and the ClinicalTrials.gov database up to December 2013. Outcomes
of interest were enzymatic infarct size, infarct size assessed by cardiac magnetic
resonance (CMR), complete ST-segment resolution (cSTR) and cardiac events during
follow-up. A Bayesian network meta-analysis was performed using WinBUGS 1.43
and R 3.02.
Results: Sixteen studies including results of 1773 IPC and RIPC patients were
identiﬁed. Pooled results showed no signiﬁcant decrease in enzymatic infarct size
among patients treated with IPC compared to RIPC (standardized mean difference
[SMD], -0.17; 95% Conﬁdence Interval [CI], -6.62 to 6.57). Compared with IPC,
RIPC tended to reduce infarct size evaluated by CMR. (Mean difference [MD],
2.77%; 95%CI,-6.40% to 12.17%).There was a trend toward more cSTR in IPC pa-
tients than in RIPC subjects (odds ratio [OR], 1.54; 95%CI, 0.42 to 4.18). There was
no signiﬁcant difference in mortality (OR, 0.79; 95%CI, 0.02 to 3.53) or reinfarction
(OR, 1.05; 95%CI, 0.001 to 4.42) during 1 month to 3.4 years among patients treated
with IPC compared to RIPC.
Conclusions: In STEMI patients undergoing pPCI, available evidence from this
network meta-analysis suggests the non-superiority of IPC vs RIPC on infarct size,
cSTR and incidence of mortality or reinfarction. Further head-to-head in-
vestigations are necessary to evaluate the effect of two adjunctive therapies during
pPCI.GW25-e3237
Usefulness of the index of microcirculatory resistance for assessing clinical
outcome in short term after percutaneous coronary intervention for
sub-acute myocardial infarction
Zhu Qingyi, Zhou Shenghua, Hu Xinqun
The Second Xiangya Hospital of Central South University
Objectives: The objective of this study is to evaluate the clinical value of the index of
microcirculatory resistance (IMR) for assessing short period prognosis of patients with
sub-acute myocardial infarction undergoing elective percutaneous coronary inter-
vention (PCI).
Methods: In 54 stable patients with ST-segment elevation myocardial infarction after
11.13.3days from symptom onset, IMR was measured after successful PCI. 28
(52%) patients had normal IMR value (IMR <32U, 19.87.3U) and 26 (48%) pa-
tients with IMR>32U (60.721.9U). Transthoracic echocardiography, 6 minutes
walking test and major adverse cardiac events (MACE) were followed up at
39.37.23 days.
Results: IMR correlated signiﬁcantly with 6 minutes walking distances (r ¼-0.504,
P<0.001), but not signiﬁcantly with left ventricular ejection fraction (LVEF)
(r ¼-0.074, P ¼0.595). There were no people reoccurred myocardial infarction or stent
re-implantation. The re-admission rate of patients with normal and abnormal IMR was
2 (7%) and 6 (23%), respectively (P¼0.135). Patients with normal IMR had less
recurrence of angina pectoris compared with patients with higher IMR (4[14%] vs. 12
[46%], P¼0.016), and IMR demonstrated signiﬁcant correlation with recurrence of
angina (r ¼0.352, P ¼0.009).
Conclusions: IMR can be regarded as a predictor of the quality of life of patients
with sub-acute myocardial infarction undergoing elective PCI in short term. But it is
not reliable in assessing the left ventricular function recovery and MACE in
short term.GW25-e4113
A randomized clinical study comparing using a single MAC guiding catheter
with conventional approach via radial artery for coronary angiography and
intervention in patients with ST elevation myocardial infarction
Guo Jincheng, Guozhong Wang, Fuli Zhu, Yuping Wang, Guowang Gao,
Jianchun Wang, Jincheng Guo
Luhe hospital, Tonghzou District, Beijing
Objectives: Coronary intervention using transradial approach is common worldwide.
It is normally necessary to use one diagnostic catheter and guiding catheter in primary
percutaneous coronary intervention (PCI) for ST elevation myocardial infarction
(STEMI). It is unknown whether using a single guiding catheter for both nonculpritardiovascular Disease Clinical Research C139
